Christopher M. Counter

Department of Pharmacology and Cancer Biology, Duke University Medical Center/Department of Radiation Oncology, Duke University Medical Center

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers82 papers

Sort

By YearBy Citation

Expression of transgenes enriched in rare codons is enhanced by the MAPK pathway

Jackson Peterson, Siqi Li, Erin Kaltenbrun, Ozgun Erdogan,Christopher M Counter

Scientific reports, no. 1 (2020): 22166

WOSBibtex

Abstract 1085: Interrogating the RAS interactome identifies EFR3A as a novel enhancer of RAS oncogenesis

Hema Adhikari, Walaa Kattan,John F. Hancock,Christopher M. Counter

Cancer Research, (2020): 1085-1085

Bibtex

Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo

Jessica K Sawyer,Zahra Kabiri,Ruth A Montague, Scott R Allen, Rebeccah Stewart, Sarah V Paramore, Erez Cohen, Hamed Zaribafzadeh,Christopher M Counter,Donald T Fox

PLoS genetics, no. 12 (2020)

WOSBibtex

Capturing the primordial Kras mutation initiating urethane carcinogenesis

Siqi Li, David M MacAlpine,Christopher M Counter

Nature communications, no. 1 (2020): 1800

WOSBibtex

A novel intensity-specific screen identifies RpS21 as a modifier of low-intensity MAPK signaling

Jessica K Sawyer, Zahra Kabiri,Ruth A Montague,Sarah V Paramore, Erez Cohen, Hamed Zaribafzadeh,Christopher M Counter,Donald T Fox

bioRxiv, pp.650630-41, (2019)

Bibtex

Wild-type Kras expands and exhausts hematopoietic stem cells

Joshua P Sasine,Heather A Himburg, Christina M Termini, Martina Roos, Evelyn Tran,Liman Zhao, Jenny Kan, Michelle Li, Yurun Zhang, Stéphanie C de Barros,Dinesh S Rao,Christopher M Counter

JCI INSIGHT, no. 11 (2018)

Cited by2WOSBibtex

Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells

Zahra Kabiri, Gediminas Greicius,Hamed Zaribafzadeh, Amanda Hemmerich,Christopher M Counter,David M Virshup

The Journal of clinical investigation, no. 9 (2018): 3806-3812

Cited by5WOSBibtex

Codon usage regulates human KRAS expression at both transcriptional and translational levels

Jingjing Fu,Yunkun Dang,Christopher Counter,Yi Liu

The Journal of biological chemistry, (2018)

WOSBibtex

A model for RAS mutation patterns in cancers: finding the sweet spot

Siqi Li,Allan Balmain,Christopher M. Counter

Nature Reviews Cancer, no. 12 (2018): 767-777

Cited by1Bibtex

Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability

Hema Adhikari,Christopher M Counter

Nature communications, no. 1 (2018): 3646

Cited by3WOSBibtex

Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer

MengMeng Xu, Michael Casio, Danielle E Range,Julie A Sosa,Christopher M Counter

Clinical cancer research : an official journal of the American Association for Cancer Research, (2018)

Cited by1WOSBibtex

Copper chelation as targeted therapy in a genetic mouse model of oncogenic BRAF-driven thyroid cancer

MengMeng Xu, Danielle Range,Julie Ann Sosa,Christopher M. Counter

Journal of Clinical Oncology, (2017)

Bibtex

Abstract IA14: Rare codons capacitate Kras-driven de novo tumorigenesis

Nicole L.K. Pershing,Benjamin L. Lampson,Christopher M. Counter

Cancer Research, (2017)

Bibtex

Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance

Moiez Ali, Erin Kaltenbrun,Grace R Anderson,Sarah Jo Stephens,Sabrina Arena,Alberto Bardelli,Christopher M Counter,Kris C Wood

Nature communications, (2017): 15617

Cited by10WOSBibtex

A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution

Grace R Anderson,Peter S Winter,Kevin H Lin,Daniel P Nussbaum, Merve Cakir, Elizabeth M Stein, Ryan S Soderquist, Lorin Crawford, Jim C Leeds, Rachel Newcomb, Priya Stepp, Catherine Yip

Cell Reports, no. 4 (2017): 999-1015

Cited by9WOSBibtex

Overexpression of Wild-Type KRAS Promotes Hematopoietic Stem Cell Expansion and Self-Renewal without Induction of Malignancy